EFdA-TP

Modify Date: 2024-01-10 10:07:12

EFdA-TP structure	Common Name	EFdA-TP
	CAS Number	950913-56-1	Molecular Weight	533.19
	Density	N/A	Boiling Point	N/A
	Molecular Formula	C₁₂H₁₅FN₅O₁₂P₃	Melting Point	N/A
	MSDS	N/A	Flash Point	N/A

Use of EFdA-TP

EFdA-TP is a potent nucleoside reverse transcriptase (RT) inhibitor. EFdA-TP inhibits RT-catalyzed DNA synthesis as an effective immediate or delayed chain terminator (ICT or DCT). EFdA-TP inhibits HIV-1 RT with multiple mechanisms[1].

Name	EFdA-TP

Description	EFdA-TP is a potent nucleoside reverse transcriptase (RT) inhibitor. EFdA-TP inhibits RT-catalyzed DNA synthesis as an effective immediate or delayed chain terminator (ICT or DCT). EFdA-TP inhibits HIV-1 RT with multiple mechanisms[1].
Related Catalog	Signaling Pathways >> Anti-infection >> HIV Research Areas >> Infection Signaling Pathways >> Cell Cycle/DNA Damage >> DNA/RNA Synthesis Signaling Pathways >> Anti-infection >> Reverse Transcriptase
Target	HIV-1
In Vitro	EFdA-TP (0.05-10 μM; for 15 min) inhibits RT-catalyzed DNA synthesis as an ICT or DCT[1]. EFdA-TP can block RT as a translocation-defective RT inhibitor that dramatically slows DNA synthesis, acting as a de facto immediate chain terminator. EFdA-TP can function as a delayed chain terminator, allowing incorporation of an additional dNTP before blocking DNA synthesis[1].
References	[1]. Eleftherios Michailidis, et al. 4'-Ethynyl-2-fluoro-2'-deoxyadenosine (EFdA) inhibits HIV-1 reverse transcriptase with multiple mechanisms. J Biol Chem. 2014 Aug 29;289(35):24533-48. [2]. Martin Markowitz, et al. 4'-Ethynyl-2-fluoro-2'-deoxyadenosine, MK-8591: a novel HIV-1 reverse transcriptase translocation inhibitor. Curr Opin HIV AIDS. 2018 Jul;13(4):294-299.

Molecular Formula	C₁₂H₁₅FN₅O₁₂P₃
Molecular Weight	533.19

Hazard Codes	Xi

EFdA-TP

Use of EFdA-TP

Names

EFdA-TP Biological Activity

Chemical & Physical Properties

Safety Information